Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in macroalbuminuric, diabetic patients.

被引:0
|
作者
Sidharta, PN
Wagner, FD
Jungik, A
Halabi, A
Dingemanse, J
机构
[1] Actel Pharmaceut Ltd, Allschwil, Switzerland
[2] 3ClinRes AG, Hennigsdorf, Germany
[3] PHAROS GmbH, Ulm, Germany
[4] IKP GmbH, Kiel, Germany
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
47
引用
收藏
页码:1078 / 1078
页数:1
相关论文
共 50 条
  • [41] Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
    Ogawa, Akiko
    Ohira, Seiya
    Kato, Yuri
    Ikuta, Tatsuya
    Yanagida, Shota
    Mi, Xinya
    Ishii, Yukina
    Kanda, Yasunari
    Nishida, Motohiro
    Inoue, Asuka
    Wei, Fan-Yan
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [42] Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
    Akiko Ogawa
    Seiya Ohira
    Yuri Kato
    Tatsuya Ikuta
    Shota Yanagida
    Xinya Mi
    Yukina Ishii
    Yasunari Kanda
    Motohiro Nishida
    Asuka Inoue
    Fan-Yan Wei
    Communications Biology, 6
  • [43] Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists
    Jin, J
    Dhanak, D
    Knight, SD
    Widdowson, K
    Aiyar, N
    Naselsky, D
    Sarau, HM
    Foley, JJ
    Schmidt, DB
    Bennett, CD
    Wang, B
    Warren, GL
    Moore, ML
    Keenan, RM
    Rivero, RA
    Douglas, SA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (13) : 3229 - 3232
  • [44] Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist
    Bandholtz, Sebastian
    Erdmann, Sarah
    von Hacht, Jan Lennart
    Exner, Samantha
    Krause, Gerd
    Kleinau, Gunnar
    Groetzinger, Carsten
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (22) : 10100 - 10112
  • [45] Discovery of New Potent Ligands at Human Urotensin-II Receptor
    Yousif, Ali Munaim
    Merlino, Francesco
    Carotenuto, Alfonso
    Limatola, Antonio
    Santicioli, Paolo
    Campiglia, Pietro
    Meini, Stefania
    Maggi, Carlo A.
    Novellino, Ettore
    Gireco, Paolo
    BIOPOLYMERS, 2013, 100 (03) : 308 - 308
  • [46] Cloning and pharmacological characterization of the cat urotensin-II receptor (UT)
    Aiyar, N
    Johns, DG
    Ao, ZH
    Disa, J
    Behm, DJ
    Foley, JJ
    Buckley, PT
    Sarau, HM
    van-der-Keyl, HK
    Elshourbagy, NA
    Douglas, SA
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (07) : 1069 - 1079
  • [47] THE STATUS OF SERUM UROTENSIN-II IN PATIENTS WITH ERECTILE DYSFUNCTION
    Singh, S. K.
    Prasad, Durga B.
    Mavuduru, R.
    Mandal, A. K.
    Prasad, R.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S302 - S303
  • [48] Gβγ-dependent Transactivation of the Epidermal Growth Factor Receptor by the Urotensin-II Receptor
    Esposito, Giovanni
    Schiattarella, Gabriele G.
    Di Serafino, Luigi
    Cannavo, Alessandro
    Borgia, Francesco
    Pironti, Gianluigi
    Franzone, Anna
    Sannino, Anna
    Perrino, Cinzia
    Chiariello, Massimo
    CIRCULATION, 2009, 120 (18) : S1167 - S1167
  • [49] Palosuran, oral antagonist of urotensin II, prevents the cardiac damage induced by high fructose diet in rats
    Cosenzi, A.
    Bernobich, E.
    Tomasella, S.
    Borri, A.
    Kogoj, P.
    Stebel, M.
    Bellini, G.
    JOURNAL OF HYPERTENSION, 2006, 24 : S379 - S379
  • [50] Urotensin II receptor antagonist palosuran lowers portal pressure by activation of mesenterial RhoA/Rho-kinase signalling in liver cirrhosis
    Trebicka, Jonel
    Eckhardt, Andreas
    Hennenberg, Martin
    Biecker, Erwin
    Lammert, Frank
    Sauerbruch, Tilman
    Heller, Joerg
    HEPATOLOGY, 2007, 46 (04) : 607A - 607A